Haematology 2018

IBRUTINIB IN B-CELL LYMPHOMA

56 patients with R/R NHL, CLL, or WM who had failed  1 previous therapy

Responders (n/N)

Mantle cell

7/9

CLL/SLL

11/16

FL

6/16

DLBCL

2/7

WM

3/4

MZL

1/4

ORR 60% N=56. Median 3 (1‒10) prior therapies

Advani RH et al. J Clin Oncol 2013;31:88‒94